Nov 11, 2021
Sheeza Hussain is the Chief Commercial Officer of Biofourmis which is developing a hospital-at-home model for health systems that is even more in demand due to the stress of COVID-19 patients. In addition to acute care, Biofourmis is also applying its remote monitoring technology to post-acute and chronic care.
Sheeza explains, "When we think about hospital-at-home, we think about acute level type care-at-home. It's not about being cared for exactly as you would be in a hospital. But it's for those patients who still, for all intents and purposes, need to be monitored and need to be admitted to a hospital. But instead, they get to go home. They get monitoring equipment, they get to go to the comfort of their own bed, and they're still visited by clinicians or physicians every day in person as is a requirement for some of the reimbursement."
"So when it comes to hospital-at-home, it's about in our case, a patch and we're device agnostic. We offer a patch that the patient wears on their chest, and it is continuously capturing data, things like the single-lead ECG, heart rate, respiratory rate. And that is feeding our analytics engine and allowing us to be able to establish a personalized baseline for each and every patient."
@Biofourmis #HospitalatHome #RemoteCare #CareatHome #PatientMonitoring #PostAcute #ChronicCare #Hospitals
